S19-243 PD-L1 Antibody Fragments Conjugated to PEG-PLGA Nanoparticles Researchers in the Felsher Lab at Stanford University have developed PD-L1 antibody fragment-conjugated nanoparticles to improve upon existing cancer immunotherapies and extend the range of indications to solid tumors. Sibu Kuruvilla Dean Felsher Christina Lee